{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:01:42Z","timestamp":1784966502101,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T00:00:00Z","timestamp":1202428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s10549-008-9912-9","type":"journal-article","created":{"date-parts":[[2008,2,7]],"date-time":"2008-02-07T17:17:20Z","timestamp":1202404640000},"page":"137-144","source":"Crossref","is-referenced-by-count":49,"title":["Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93"],"prefix":"10.1007","volume":"113","author":[{"given":"Beat","family":"Th\u00fcrlimann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Gelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig B.","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Crivellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Castiglione-Gertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,8]]},"reference":[{"key":"9912_CR1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/jnci\/94.19.1433","volume":"94","author":"RR Love","year":"2002","unstructured":"Love RR, Philips J (2002) Oophorectomy for breast cancer: history revisited. J Natl Cancer Inst 94:1433\u20131434","journal-title":"J Natl Cancer Inst"},{"key":"9912_CR2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Cooperative Group","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Cooperative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687\u20131717","journal-title":"Lancet"},{"key":"9912_CR3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1200\/JCO.2001.19.2.343","volume":"19","author":"JGM Klijn","year":"2001","unstructured":"Klijn JGM, Blamey RW, Boccardo R et\u00a0al, for the Combined Hormone Agents Trialists\u2019 Group and the European Organization for Research and Treatment of Cancer (2001) Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol 19:343\u2013353","journal-title":"J Clin Oncol"},{"key":"9912_CR4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","volume":"18","author":"A Goldhirsch","year":"2007","unstructured":"Goldhirsch A, Wood WC, Gelber RD et\u00a0al (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133\u20131144","journal-title":"Ann Oncol"},{"key":"9912_CR5","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1200\/JCO.2005.05.551","volume":"23","author":"NE Davidson","year":"2005","unstructured":"Davidson NE, O\u2019Neill AM, Vukov AM et\u00a0al (2005) Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188). J Clin Oncol 23:5973\u20135982","journal-title":"J Clin Oncol"},{"key":"9912_CR6","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.2005.11.050","volume":"23","author":"S Dellapasqua","year":"2005","unstructured":"Dellapasqua S, Colleoni M, Gelber RD, Goldhirsch A (2005) Adjuvant endocrine therapy for premenopausal women with early breast cancer. J Clin Oncol 23:1736\u20131750","journal-title":"J Clin Oncol"},{"key":"9912_CR7","doi-asserted-by":"crossref","unstructured":"The [T1]Adjuvant Breast Cancer Trials Collaborative Group (2007) Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial. J Natl Cancer Inst 99:516\u2013525","DOI":"10.1093\/jnci\/djk109"},{"issue":"Suppl 3","key":"9912_CR8","first-page":"130","volume":"10","author":"International Breast Cancer Study Group","year":"2001","unstructured":"International Breast Cancer Study Group (2001) Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93. Breast 10 (Suppl 3):130\u2013138","journal-title":"Breast"},{"key":"9912_CR9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","volume":"319","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1988","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1988) Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women. N Engl J Med 319:1681\u20131692","journal-title":"N Engl J Med"},{"key":"9912_CR10","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1200\/JCO.2005.03.0783","volume":"24","author":"International Breast Cancer Study Group","year":"2006","unstructured":"International Breast Cancer Study Group (2006) Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: IBCSG Trial 13-93. J Clin Oncol 24:1332\u20131341","journal-title":"J Clin Oncol"},{"key":"9912_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"9912_CR12","volume-title":"The natural duration of cancer","author":"M Greenwood","year":"1926","unstructured":"Greenwood M (1926) The natural duration of cancer. HM Stationary Office, London"},{"key":"9912_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life-tables (with discussion). J R Stat Soc 34:187\u2013220","journal-title":"J R Stat Soc"},{"key":"9912_CR14","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1200\/JCO.2007.11.3290","volume":"25","author":"NL Henry","year":"2007","unstructured":"Henry NL, Hayes DF (2007) Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy? J Clin Oncol 25:2501\u20132503","journal-title":"J Clin Oncol"},{"key":"9912_CR15","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/annonc\/mdl299","volume":"17","author":"NG Leining","year":"2006","unstructured":"Leining NG, Gelber S, Rosenberg R et\u00a0al (2006) Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 17:1777\u20131782","journal-title":"Ann Oncol"},{"key":"9912_CR16","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/jnci\/djg119","volume":"95","author":"International Breast Cancer Study Group","year":"2003","unstructured":"International Breast Cancer Study Group (2003) Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 95:1833\u20131846","journal-title":"J Natl Cancer Inst"},{"key":"9912_CR17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/bcr1334","volume":"7","author":"KN Price","year":"2005","unstructured":"Price KN, Goldhirsch A, for the IBCSG (2005) Clinical trial update: international Breast Cancer Study Group. Breast Cancer Res 7:252\u2013254","journal-title":"Breast Cancer Res"},{"key":"9912_CR18","unstructured":"National Cancer Institute. US National Institutes of Health. The TAILORx breast cancer trial. http:\/\/www.cancer.gov\/clinicaltrials\/digestpage\/TAILORx"},{"key":"9912_CR19","unstructured":"Breast International Group. MINDACT (microarray in node negative disease may avoid chemotherapy). http:\/\/www.breastinternationalgroup.org\/TransBIG\/Mindact.aspx"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-9912-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-008-9912-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-9912-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T04:51:31Z","timestamp":1737953491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-008-9912-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,8]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["9912"],"URL":"https:\/\/doi.org\/10.1007\/s10549-008-9912-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,8]]}}}